The presentation highlights the key challenges in the production of cytostatics under the new Annex 1 guidelines and demonstrates how the cytostatics isolator by Ortner Reinraumtechnik addresses them. The isolator not only provides maximum protection for personnel but also ensures consistently high product quality through precise process control and automation.
With a modular design, the isolator is suitable even for pharmacies with limited space, without compromising on safety or efficiency. The advanced technology minimizes error sources, facilitates compliance with stringent regulations, and optimizes production workflows.
Through practical examples, the presentation will showcase how the cytostatics isolator reduces the risk of manual errors, improves traceability in production, and fully meets Annex 1 regulatory requirements. This positions Ortner Reinraumtechnik as an innovative partner for future-proof pharmaceutical manufacturing.